Benzinga's Top Initiations
February 17, 2015 at 09:23 AM EST
Analysts at Bernstein initiated coverage on Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) with a Outperform rating. The target price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.